OGTAC Chimeras for Protein-Specific O-GlcNAcylation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for studying protein-specific O-GlcNAcylation are limited by the lack of chemical tools for precise intervention and the potential for off-target effects when inhibiting O-GlcNAc transferase (OGT) or O-GlcNAcase (OGA).

Innovation Solution

Development of O-GlcNAcylation targeting chimeras (OGTACs), which recruit OGT to specific proteins of interest (POIs) using a heterobifunctional system, enabling protein-specific O-GlcNAcylation with temporal and magnitude control.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If chemical tools are used to inhibit OGT or OGA, then protein-specific O-GlcNAcylation can be studied, but off-target effects occur

Engineering Contradiction:
Improveprotein-specific O-GlcNAcylation studyVSAvoidoff-target effects
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent uses a heterobifunctional small molecule (proximity inducing ligand) as an intermediary to bridge the FKBP12F36V-OGT fusion protein and the Halotag-POI fusion protein. This mediator enables specific recruitment of OGT to the target protein without directly inhibiting OGT or OGA enzymes, thereby avoiding off-target effects while achieving protein-specific O-GlcNAcylation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system is divided into separate functional components: the FKBP12F36V proximity inducing protein fused to OGT, the Halotag proximity inducing protein fused to the POI, and the heterobifunctional small molecule ligand. This segmentation allows independent optimization of each component and enables precise spatial and temporal control of the labeling process.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If existing O-GlcNAcylation methods are used, then general O-GlcNAcylation can be detected, but protein-specific labeling cannot be achieved

Engineering Contradiction:
Improveprotein-specific labelingVSAvoidlabeling system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs universal proximity inducing protein tags (FKBP12F36V and Halotag) that can be applied to any target protein of interest. These tags work with a common heterobifunctional small molecule ligand system, allowing the same labeling approach to be universally applied across different proteins while achieving protein-specific labeling. The system combines multiple functions: protein tagging, specific recruitment, and enzymatic labeling.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Manufacturing precision

If OGT is recruited to POI using proximity inducing proteins, then specific O-GlcNAcylation is achieved, but the system complexity increases

Engineering Contradiction:
Improvespecific O-GlcNAcylationVSAvoiddual fusion protein system
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The proximity inducing proteins (FKBP12F36V and Halotag) have inherent, high-affinity binding sites for their respective ligand portions. This self-service capability allows the system to automatically recruit OGT to the target protein through the heterobifunctional ligand without requiring additional complex recruitment mechanisms or multiple interaction interfaces.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

OGTACs allow for the efficient and specific induction of O-GlcNAcylation on target proteins like BRD4, CK2α, and EZH2, with dose- and time-dependent effects, and site-specific validation using LC-MS/MS, demonstrating a promising approach for functional dissection and therapeutic applications.

Implementation Method 1

a first portion that is recognized and bound by the first proximity inducing protein

Methodology Applied
Scientific EffectLigand-protein binding:

Implementation Method 2

a second portion that is recognized and bound by the second proximity protein

Methodology Applied
Scientific EffectLigand-protein binding:

Implementation Method 3

the glycan transferase to label the POI with a glycan

Methodology Applied
Scientific EffectEnzymatic glycosylation: Enzyme

Data Source

PatentUS20250035641A1Compositions and methods related to protein labeling
Publication Date: 2025.01.30 THE CHINESE UNIVERSITY OF HONG KONG
  • US20250035641A1 patent drawing
  • US20250035641A1 patent drawing
  • US20250035641A1 patent drawing

AI summary

The disclosure provides compositions and methods for labeling a protein with a glycan by a glycan transferase by using a proximity inducing ligand.